What are the poor prognostic markers after cardiopulmonary resuscitation (CPR)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Poor Prognostic Markers After CPR

Use a multimodal approach requiring at least two concordant poor prognostic markers at ≥72 hours after ROSC to predict poor neurological outcome with high certainty, avoiding premature withdrawal of life-sustaining therapy based on single findings. 1

Critical Timing Consideration

Do not make definitive prognostic decisions before 72 hours after ROSC - neurological prognosis remains uncertain in this early period, and sedation/paralysis effects can confound clinical examination 1, 2. The 2025 ERC-ESICM guidelines emphasize this timeline was validated with 0% false positive rate (95% CI 0-3.7%) across 1,791 patients 1.

Clinical Examination Findings (≥72 hours post-ROSC)

Highly Reliable Markers:

  • Bilaterally absent pupillary light reflexes: 1% FPR (0-3%) with 19% sensitivity 2

    • Use automated pupillometry when available for objective measurement 1
    • Caution: Drug overdose, resuscitation medications, and low cardiac output can cause false positives 3

  • Bilaterally absent corneal reflexes: 2% FPR (0-7%) with 25% sensitivity 2

  • Combined absence of pupillary AND corneal reflexes: 0% FPR (0-8%) with 15% sensitivity 2

Less Reliable Markers:

  • Motor response ≤2 (absent/extensor posturing): 10% FPR (7-15%) - too high to use alone 4

    • However, useful for identifying patients needing prognostication due to high sensitivity 2

  • Status myoclonus (continuous generalized myoclonus >30 minutes within first 72 hours): 0% FPR (0-4%) with 16% sensitivity 2

    • Critical distinction: Simple myoclonus has 5-11% FPR and should NOT be used alone 4
    • Some patients with early myoclonus develop Lance-Adams syndrome but achieve good recovery 2

Electrophysiology

Somatosensory Evoked Potentials (SSEPs):

Bilaterally absent N20 wave at 24-72 hours: Most robust predictor with 0-2% FPR (0-4%) and 28-46% sensitivity 2, 5

  • Requires skilled interpretation and careful avoidance of electrical interference 2
  • Remains reliable in both TTM-treated and non-TTM patients 4

Electroencephalography (EEG):

  • Highly malignant patterns (suppressed background with periodic discharges or burst-suppression) after 24 hours: Associated with poor outcome 1
  • Burst suppression at 72 hours: 0% FPR (0-11%) 2
  • Unreactive EEG within 72 hours: Variable specificity (41.7-100%), reaching 100% in only 2 studies 5
  • Status epilepticus: 7-11.5% FPR in TTM patients - not sufficiently reliable alone 6

Important caveat: EEG grading systems lack standardization and should not be used for prognostication 2

Biomarkers

Neuron-specific enolase (NSE) >60 µg/L at 48-72 hours: Supports poor prognosis when combined with other markers 1

  • Critical limitation: No threshold enables 0% FPR prediction 2
  • Rising NSE levels between 24-48h and 48-72h further support poor outcome 1
  • Should NOT be used alone due to unacceptable false positive rates 4

Neuroimaging

CT Findings:

  • Diffuse brain swelling at 72 hours: 0% FPR (0-45%) with 52% sensitivity 2
  • Gray-white matter ratio (GWR): CN/PIC ratio <1.22 within 24h or <1.18 within 48h predicts poor outcome 2
    • Requires experienced neuroradiologist interpretation 1

MRI Findings:

  • Extensive diffusion restriction (cortex, basal ganglia, cerebellum) at 2-6 days: 0% FPR in small studies 2
  • Whole-brain ADC <665×10⁻⁶ mm²/s: 0% FPR (0-21%) with 40% sensitivity 2
  • Limitation: Not feasible in unstable patients; MRI magnetic field interferes with ECMO pumps 1

The 2021/2025 Prognostication Algorithm

For comatose patients with motor response no better than abnormal flexion at ≥72h after ROSC, predict poor outcome when ≥2 concordant signs are present:

  1. Bilaterally absent pupillary/corneal reflexes (≥72h)
  2. Bilaterally absent N20 SSEP wave
  3. Highly malignant EEG patterns (after 24h)
  4. NSE >60 µg/L at 48-72h (or rising levels)
  5. Status myoclonus (first 72-120h)
  6. Diffuse extensive anoxic injury on CT/MRI

Validated performance: 0% FPR (95% CI 0-3.7%) across three multicenter studies 1

Critical Pitfalls to Avoid

  • Self-fulfilling prophecy bias: In validation studies, almost half of patients had indeterminate outcomes, and 21% of these achieved neurological recovery 1
  • Sedation interference: Prolong observation when residual sedation/paralysis suspected 2
  • Premature assessment: No findings reliably predict outcome <24 hours post-ROSC 6
  • Single marker reliance: Even highly specific markers have poor sensitivity (15-46%), missing many patients with poor outcomes 7
  • TTM effects: Therapeutic hypothermia delays CNS recovery and drug metabolism, potentially affecting timing and reliability of some markers 2

Special Populations

Drug overdose patients: May have absent pupillary reflexes but still achieve good outcomes - exercise extreme caution 3

Active hematologic malignancy: Associated with higher 60-day mortality independent of arrest characteristics 8

References

Related Questions

What are the chances of recovery from cardiac arrest with fixed dilated pupils?
What is the time frame from cardiac arrest to dilation and fixation of pupils?
A 10‑day postpartum woman presents with dysuria and a urine culture growing mixed microbiota >100,000 CFU/mL; how should this be managed?
In a 10‑month‑old infant with a slightly indented coronal suture, normal fontanelles, and appropriate head growth, what is the appropriate next step in management?
What is the appropriate 10‑day antibiotic regimen for a patient undergoing ENT follow‑up after image‑guided fine‑needle aspiration/biopsy, assuming no documented β‑lactam allergy?
How should I manage a fixed drug eruption in a septic patient receiving meropenem and teicoplanin when these antibiotics are not the cause?
How should acute coronary syndrome presenting as a non‑ST‑segment elevation myocardial infarction be managed in a patient who is 10 weeks pregnant (first trimester)?
Are there any laboratory tests that can be used to diagnose lung cancer?
In a 64-year-old woman with type 2 diabetes and established atherosclerotic cardiovascular disease who needs additional glucose‑lowering therapy, which medication class offers proven cardiovascular and renal protection?
What are the major pharmacologic drug classes, their representative agents, typical clinical uses, and usual dosing regimens?
In a 69-year-old man with fever, elevated erythrocyte sedimentation rate, lower back pain localized to the L4‑L5 vertebrae, mild degenerative changes on lumbar spine X‑ray, and a recent urinary tract infection treated with ciprofloxacin, what is the most appropriate next step in management?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.